GLP-1s are not just diabetes drugs anymore
Six FDA-approved indications, oral formulations from late 2025 and April 2026, and emerging data on wound healing and PAD. A wound care physician's guide to what the evidence supports and what it means for the multi-morbid patients we share.
Read article